These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 37267526)
1. Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations. Allen LV Int J Pharm Compd; 2023; 27(3):223-229. PubMed ID: 37267526 [TBL] [Abstract][Full Text] [Related]
2. Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations. Allen LV Int J Pharm Compd; 2023; 27(2):123-139. PubMed ID: 37000138 [TBL] [Abstract][Full Text] [Related]
3. Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation. Allen LV Int J Pharm Compd; 2021; 25(3):222-229. PubMed ID: 34125713 [TBL] [Abstract][Full Text] [Related]
4. Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation. Allen LV Int J Pharm Compd; 2021; 25(2):131-139. PubMed ID: 33798113 [TBL] [Abstract][Full Text] [Related]
5. Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates. Allen LV Int J Pharm Compd; 2020; 24(3):215-220. PubMed ID: 32401741 [TBL] [Abstract][Full Text] [Related]
6. Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations. Allen LV Int J Pharm Compd; 2020; 24(4):305-309. PubMed ID: 32649304 [TBL] [Abstract][Full Text] [Related]
7. Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved. Allen LV Int J Pharm Compd; 2020; 24(1):44-50. PubMed ID: 32023216 [TBL] [Abstract][Full Text] [Related]
8. Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues. Allen LV Int J Pharm Compd; 2021; 25(4):311-317. PubMed ID: 34297694 [TBL] [Abstract][Full Text] [Related]
9. Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications. Allen LV Int J Pharm Compd; 2020; 24(5):397-402. PubMed ID: 32886638 [TBL] [Abstract][Full Text] [Related]
10. Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations. Allen LV Int J Pharm Compd; 2021; 25(1):31-38. PubMed ID: 33503008 [TBL] [Abstract][Full Text] [Related]
13. Intravenous Admixture Preparation Considerations, Part 7: Stability Issues. Allen LV Int J Pharm Compd; 2020; 24(6):473-478. PubMed ID: 33217737 [TBL] [Abstract][Full Text] [Related]
14. Observational study of accuracy in compounding i.v. admixtures at five hospitals. Flynn EA; Pearson RE; Barker KN Am J Health Syst Pharm; 1997 Apr; 54(8):904-12. PubMed ID: 9114922 [TBL] [Abstract][Full Text] [Related]
15. Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection. Allen LV Int J Pharm Compd; 2022; 26(3):219-228. PubMed ID: 35657746 [TBL] [Abstract][Full Text] [Related]
16. Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities. Allen LV Int J Pharm Compd; 2020; 24(2):121-126. PubMed ID: 32196475 [TBL] [Abstract][Full Text] [Related]
17. Basics of Sterile Compounding: Vehicles Used in Sterile Compounding. Allen LV Int J Pharm Compd; 2019; 23(3):221-228. PubMed ID: 31085791 [TBL] [Abstract][Full Text] [Related]
18. Recommended methods for compounding intravenous admixtures in hospitals. Am J Hosp Pharm; 1975 Mar; 32(3):261-70. PubMed ID: 1136973 [TBL] [Abstract][Full Text] [Related]
19. Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations. Allen LV Int J Pharm Compd; 2021; 25(6):491-496. PubMed ID: 34807845 [TBL] [Abstract][Full Text] [Related]
20. Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics. Rayaprolu BM; Strawser JJ; Anyarambhatla G Drug Dev Ind Pharm; 2018 Oct; 44(10):1565-1571. PubMed ID: 29863908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]